# NuVera Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuvera-medical

- Industry: Medical Devices & Equipment
- Headquarters: Campbell, US
- Website: www.nuveramedical.com
- Total disclosed funding: $26M
- Latest round: Series B (Feb 6, 2019)
- Investors on record: 4

## About

NuVera Medical, Inc. is a company focused on developing innovative medical devices for electrophysiology, enhancing the diagnosis and treatment of cardiac arrhythmias through advanced technology and therapeutic solutions.NuVera Medical, Inc. specializes in electrophysiology, aiming to improve cardiac arrhythmia management. The company, based in Campbell, US, has undergone strategic changes to refine its product offerings. It has raised funding through multiple rounds, with the latest being the Series B round in February 2019, which successfully secured USD 15.00 mn led by Cormorant Asset Management, including participation from Lilly Asia Ventures and The Capital Partnership (U.K.) Limited. The total amount raised by the company stands at USD 15.00 mn, and its current valuation is USD 60.64 mn.NuVera Medical, Inc. offers advanced medical devices aimed at cardiac electrophysiology, including innovative mapping and imaging systems designed for precise visualization during cardiac procedures. Their key products include therapeutic solutions such as catheters used in catheter ablation procedures for conditions like atrial fibrillation. These products cater to electrophysiologists and healthcare facilities worldwide, particularly across North America, Europe, and Asia-Pacific, focusing on improving clinical outcomes for patients with cardiac arrhythmias.NuVera Medical generates revenue primarily from the sale of its medical devices to healthcare institutions. The sales strategy typically involves direct transactions with hospitals and physicians, supplemented by educational and clinical support services. Their flagship products, including advanced mapping systems, are sold under capital equipment agreements, while consumable items follow a product sales model. This revenue structure is supported by ongoing partnerships with medical facilities, enhancing the company's presence in the electrophysiology sector without disclosing specific financial metrics.NuVera Medical, Inc. plans to leverage its recent funding of USD 15.00 mn raised in February 2019 to support the development of new medical devices tailored for cardiac electrophysiology. The company is also targeting expansion into additional markets, specifically across Europe and Asia-Pacific, within the next two years. The funding will be utilized to enhance product development and facilitate entry into these new geographic regions, aligning with its strategic vision for growth.

## Funding rounds

- Series B, Feb 6, 2019, $15M — Lilly Asia Ventures, Cormorant Asset Management, The Capital Partnership (U.K.) Limited
- Series A, Jun 28, 2017, $11M — Lilly Asia Ventures, Cormorant Asset Management, GE Ventures, The Capital Partnership (U.K.) Limited

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A, Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series A, Series B
- GE Ventures — Series A
- The Capital Partnership (U.K.) Limited — Series A, Series B